22 PATIENTS RECEIVED SO FAR. MORE THAN 20 MASS CASUALTIES HANDLED BY EMERGENCY IN KABUL SINCE THE BEGINNING OF THE YEAR.  A total of 22 patients, including 20 women, have been received at EMERGENCY’s Surgical Centre for War Victims in Kabul following the suicide attack that took place this morning, 30 September, inside an educational […]

3 million people died since the Omicron variant emerged, shattering perceptions that the pandemic is over The COVID-19 death toll has been four times higher in lower-income countries than in rich ones, according to a new report published today by Oxfam on behalf of the People’s Vaccine Alliance as the world marks two years since […]

Europe has betrayed Africa by blocking proposals which would allow manufacturers on the continent to make their own COVID-19 vaccines while hoarding millions of doses which are set to expire at the end of the month, warns the People’s Vaccine Alliance ahead of tomorrow’s meeting of African and European leadersat the AU-EU Summit. According to […]

Just like every year, EMERGENCY and Ogilvy are back with a wish for the year ahead. The message “Let’s make 2022 a year of peace, not war” took on life with a video distributed on EMERGENCY’s global social media channels, and with a public advertising campaign at 100 locations across underground stations in Milan, Italy. […]

Firms and rich nations continue to block moves to share vaccine technology and recipes Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies, who are failing to deliver billions of doses they promised while blocking the real solutions to vaccine inequality, according to […]

Moderna, BioNTech and Pfizer cashing in thanks to taxpayer investments, monopolies, and low taxes while leaving millions unprotected Moderna, BioNTech, and Pfizer are reaping astronomical and unconscionable profits due to their monopolies of mRNA COVID vaccines — upwards of 69% profit margins in the case of Moderna and BioNTech — while Moderna and Pfizer are […]